Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 203

    1.

    Metallothionein isoform 3 as a potential biomarker for human bladder cancer.

    Sens MA, Somji S, Lamm DL, Garrett SH, Slovinsky F, Todd JH, Sens DA.

    Environ Health Perspect. 2000 May;108(5):413-8.PMID: 10811567 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-1X mRNA in bladder cancer.

    Somji S, Sens MA, Lamm DL, Garrett SH, Sens DA.

    Cancer Detect Prev. 2001;25(1):62-75.PMID: 11270423 [PubMed - indexed for MEDLINE]Related articles

    3.

    Metallothionein-1 and -2 expression in cadmium- or arsenic-derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer.

    Zhou XD, Sens DA, Sens MA, Namburi VB, Singh RK, Garrett SH, Somji S.

    Toxicol Sci. 2006 Jun;91(2):467-75. Epub 2006 Mar 24.PMID: 16565513 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Enhanced expression of metallothionein isoform 3 protein in tumor heterotransplants derived from As+3- and Cd+2-transformed human urothelial cells.

    Zhou XD, Sens MA, Garrett SH, Somji S, Park S, Gurel V, Sens DA.

    Toxicol Sci. 2006 Oct;93(2):322-30. Epub 2006 Jul 19.PMID: 16854967 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer.

    Garrett SH, Sens MA, Shukla D, Flores L, Somji S, Todd JH, Sens DA.

    Prostate. 2000 May 1;43(2):125-35.PMID: 10754528 [PubMed - indexed for MEDLINE]Related articles

    6.

    In vivo gene expression profile analysis of metallothionein in renal cell carcinoma.

    Nguyen A, Jing Z, Mahoney PS, Davis R, Sikka SC, Agrawal KC, Abdel-Mageed AB.

    Cancer Lett. 2000 Nov 28;160(2):133-40.PMID: 11053642 [PubMed - indexed for MEDLINE]Related articles

    7.

    Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.

    Gazzaniga P, Gradilone A, Giuliani L, Gandini O, Silvestri I, Nofroni I, Saccani G, Frati L, Aglianò AM.

    Ann Oncol. 2003 Jan;14(1):85-90.PMID: 12488298 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Metallothionein 2A expression is associated with cell proliferation in breast cancer.

    Jin R, Chow VT, Tan PH, Dheen ST, Duan W, Bay BH.

    Carcinogenesis. 2002 Jan;23(1):81-6.PMID: 11756227 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.

    Amara N, Palapattu GS, Schrage M, Gu Z, Thomas GV, Dorey F, Said J, Reiter RE.

    Cancer Res. 2001 Jun 15;61(12):4660-5.PMID: 11406532 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Increased expression of EZH2, a polycomb group protein, in bladder carcinoma.

    Arisan S, Buyuktuncer ED, Palavan-Unsal N, Caşkurlu T, Cakir OO, Ergenekon E.

    Urol Int. 2005;75(3):252-7.PMID: 16215315 [PubMed - indexed for MEDLINE]Related articles

    11.

    KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer.

    Huang WC, Taylor S, Nguyen TB, Tomaszewski JE, Libertino JA, Malkowicz SB, McGarvey TW.

    DNA Cell Biol. 2002 Oct;21(10):707-15.PMID: 12443540 [PubMed - indexed for MEDLINE]Related articles

    12.

    Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer.

    Fauconnet S, Bernardini S, Lascombe I, Boiteux G, Clairotte A, Monnien F, Chabannes E, Bittard H.

    Oncol Rep. 2009 Jun;21(6):1495-504.PMID: 19424629 [PubMed - indexed for MEDLINE]Related articles

    13.

    Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.

    Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP.

    Cancer. 2006 Jun 15;106(12):2610-6.PMID: 16700038 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Expression of lung resistance-related protein in transitional cell carcinoma of bladder.

    Zhu Y, Kong C, Zeng Y, Sun Z, Gao H.

    Urology. 2004 Apr;63(4):694-8.PMID: 15072883 [PubMed - indexed for MEDLINE]Related articles

    15.

    Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.

    Sachs MD, Rauen KA, Ramamurthy M, Dodson JL, De Marzo AM, Putzi MJ, Schoenberg MP, Rodriguez R.

    Urology. 2002 Sep;60(3):531-6.PMID: 12350512 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas]

    Zhan J, Tang XD.

    Ai Zheng. 2002 Nov;21(11):1212-6. Chinese. PMID: 12526218 [PubMed - indexed for MEDLINE]Related articles

    18.

    Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.

    Raman JD, Mongan NP, Tickoo SK, Boorjian SA, Scherr DS, Gudas LJ.

    Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8570-6.PMID: 16361539 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Expression of Bmi-1 is a prognostic marker in bladder cancer.

    Qin ZK, Yang JA, Ye YL, Zhang X, Xu LH, Zhou FJ, Han H, Liu ZW, Song LB, Zeng MS.

    BMC Cancer. 2009 Feb 19;9:61.PMID: 19228380 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.

    Yuasa T, Yoshiki T, Isono T, Tanaka T, Hayashida H, Okada Y.

    Int J Urol. 1999 Jun;6(6):286-92.PMID: 10404304 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data